306 related articles for article (PubMed ID: 23628818)
1. High-resolution genome-wide copy-number analyses identify localized copy-number alterations in Ewing sarcoma.
Lynn M; Wang Y; Slater J; Shah N; Conroy J; Ennis S; Morris T; Betts DR; Fletcher JA; O'Sullivan MJ
Diagn Mol Pathol; 2013 Jun; 22(2):76-84. PubMed ID: 23628818
[TBL] [Abstract][Full Text] [Related]
2. 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma.
Mackintosh C; Ordóñez JL; García-Domínguez DJ; Sevillano V; Llombart-Bosch A; Szuhai K; Scotlandi K; Alberghini M; Sciot R; Sinnaeve F; Hogendoorn PC; Picci P; Knuutila S; Dirksen U; Debiec-Rychter M; Schaefer KL; de Álava E
Oncogene; 2012 Mar; 31(10):1287-98. PubMed ID: 21822310
[TBL] [Abstract][Full Text] [Related]
3. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.
Tirode F; Surdez D; Ma X; Parker M; Le Deley MC; Bahrami A; Zhang Z; Lapouble E; Grossetête-Lalami S; Rusch M; Reynaud S; Rio-Frio T; Hedlund E; Wu G; Chen X; Pierron G; Oberlin O; Zaidi S; Lemmon G; Gupta P; Vadodaria B; Easton J; Gut M; Ding L; Mardis ER; Wilson RK; Shurtleff S; Laurence V; Michon J; Marec-Bérard P; Gut I; Downing J; Dyer M; Zhang J; Delattre O;
Cancer Discov; 2014 Nov; 4(11):1342-53. PubMed ID: 25223734
[TBL] [Abstract][Full Text] [Related]
4. Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group.
Lerman DM; Monument MJ; McIlvaine E; Liu XQ; Huang D; Monovich L; Beeler N; Gorlick RG; Marina NM; Womer RB; Bridge JA; Krailo MD; Randall RL; Lessnick SL;
Pediatr Blood Cancer; 2015 May; 62(5):759-65. PubMed ID: 25464386
[TBL] [Abstract][Full Text] [Related]
5. Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.
Agelopoulos K; Richter GH; Schmidt E; Dirksen U; von Heyking K; Moser B; Klein HU; Kontny U; Dugas M; Poos K; Korsching E; Buch T; Weckesser M; Schulze I; Besoke R; Witten A; Stoll M; Köhler G; Hartmann W; Wardelmann E; Rossig C; Baumhoer D; Jürgens H; Burdach S; Berdel WE; Müller-Tidow C
Clin Cancer Res; 2015 Nov; 21(21):4935-46. PubMed ID: 26179511
[TBL] [Abstract][Full Text] [Related]
6. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
7. Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors.
Savola S; Klami A; Tripathi A; Niini T; Serra M; Picci P; Kaski S; Zambelli D; Scotlandi K; Knuutila S
BMC Cancer; 2009 Jan; 9():17. PubMed ID: 19144156
[TBL] [Abstract][Full Text] [Related]
8. Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma.
Jahromi MS; Putnam AR; Druzgal C; Wright J; Spraker-Perlman H; Kinsey M; Zhou H; Boucher KM; Randall RL; Jones KB; Lucas D; Rosenberg A; Thomas D; Lessnick SL; Schiffman JD
Cancer Genet; 2012; 205(7-8):391-404. PubMed ID: 22868000
[TBL] [Abstract][Full Text] [Related]
9. Detection and Correlation of Single and Concomitant
Pessôa IA; Amorim CK; Ferreira WAS; Sagica F; Brito JR; Othman M; Meyer B; Liehr T; de Oliveira EHC
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151164
[TBL] [Abstract][Full Text] [Related]
10. Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience.
Warren M; Weindel M; Ringrose J; Venable C; Reyes A; Terashima K; Rao P; Chintagumpala M; Hicks MJ; Lopez-Terrada D; Lu XY
Hum Pathol; 2013 Oct; 44(10):2010-9. PubMed ID: 23706910
[TBL] [Abstract][Full Text] [Related]
11. Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors.
Tarkkanen M; Kiuru-Kuhlefelt S; Blomqvist C; Armengol G; Böhling T; Ekfors T; Virolainen M; Lindholm P; Monge O; Picci P; Knuutila S; Elomaa I
Cancer Genet Cytogenet; 1999 Oct; 114(1):35-41. PubMed ID: 10526533
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors.
Terashima K; Yu A; Chow WY; Hsu WC; Chen P; Wong S; Hung YS; Suzuki T; Nishikawa R; Matsutani M; Nakamura H; Ng HK; Allen JC; Aldape KD; Su JM; Adesina AM; Leung HC; Man TK; Lau CC
Pediatr Blood Cancer; 2014 Apr; 61(4):593-600. PubMed ID: 24249158
[TBL] [Abstract][Full Text] [Related]
13. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
Marescalco MS; Capizzi C; Condorelli DF; Barresi V
J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
[TBL] [Abstract][Full Text] [Related]
15. Unusual genetic aberrations including a deletion of KLF6 tumor suppressor gene revealed by integrated cytogenetic approaches in a pediatric ewing sarcoma.
White JC; Halligan GE; de Chadarévian JP; Pascasio JM; Punnet HH; Liu J
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e51-4. PubMed ID: 24322504
[TBL] [Abstract][Full Text] [Related]
16. A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma.
Sugita S; Arai Y; Tonooka A; Hama N; Totoki Y; Fujii T; Aoyama T; Asanuma H; Tsukahara T; Kaya M; Shibata T; Hasegawa T
Am J Surg Pathol; 2014 Nov; 38(11):1571-6. PubMed ID: 25007147
[TBL] [Abstract][Full Text] [Related]
17. Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor.
Yu J; Deshmukh H; Payton JE; Dunham C; Scheithauer BW; Tihan T; Prayson RA; Guha A; Bridge JA; Ferner RE; Lindberg GM; Gutmann RJ; Emnett RJ; Salavaggione L; Gutmann DH; Nagarajan R; Watson MA; Perry A
Clin Cancer Res; 2011 Apr; 17(7):1924-34. PubMed ID: 21325289
[TBL] [Abstract][Full Text] [Related]
18. Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.
Niemeyer BF; Parrish JK; Spoelstra NS; Joyal T; Richer JK; Jedlicka P
PLoS One; 2015; 10(1):e0116895. PubMed ID: 25603314
[TBL] [Abstract][Full Text] [Related]
19. A t(17;22)(q21;q12) with partial ETV4 deletion in a soft tissue Ewing sarcoma.
Rougemont AL; Bouron-Dal Soglio D; Patey-Mariaud de Serre N; Fetni R; Fan L; Barrette S; Fournet JC
Cancer Genet; 2012; 205(1-2):55-60. PubMed ID: 22429598
[TBL] [Abstract][Full Text] [Related]
20. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
